相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MCPIP1 inhibits Wnt/β-catenin signaling pathway activity and modulates epithelial-mesenchymal transition during clear cell renal cell carcinoma progression by targeting miRNAs
Judyta Gorka et al.
ONCOGENE (2021)
p38 Expression and Modulation of STAT3 Signaling in Oral Cancer
I. Gkouveris et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer
Tung-Yung Huang et al.
CELLS (2020)
β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion
Linyong Du et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy
Yang Gao et al.
NATURE CELL BIOLOGY (2020)
PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis
Junwei Hou et al.
NATURE CELL BIOLOGY (2020)
Resveratrol antagonizes thyroid hormone-induced expression of checkpoint and proliferative genes in oral cancer cells
Chia-Cheng Lin et al.
JOURNAL OF DENTAL SCIENCES (2019)
αvβ3-integrin regulates PD-L1 expression and is involved in cancer immune evasion
Andrea Vannini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Thyroid hormone-induced expression of inflammatory cytokines interfere with resveratrol-induced anti-proliferation of oral cancer cells
Yi-Ru Chen et al.
FOOD AND CHEMICAL TOXICOLOGY (2019)
Tetrac downregulates beta-catenin and HMGA2 to promote the effect of resveratrol in colon cancer
Andre Wendindonde Nana et al.
ENDOCRINE-RELATED CANCER (2018)
Thyroid Hormone Promotes β-Catenin Activation and Cell Proliferation in Colorectal Cancer
Yee-Shin Lee et al.
HORMONES & CANCER (2018)
Nano-Diamino-Tetrac (NDAT) Enhances Resveratrol-Induced Antiproliferation by Action on the RRM2 Pathway in Colorectal Cancers
Andre Wendindond Nana et al.
HORMONES & CANCER (2018)
Enhancement by Nano-Diamino-Tetrac of Antiproliferative Action of Gefitinib on Colorectal Cancer Cells: Mediation by EGFR Sialylation and PI3K Activation
Tung-Cheng Chang et al.
HORMONES & CANCER (2018)
STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC
L. L. Bu et al.
JOURNAL OF DENTAL RESEARCH (2017)
PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma
V. Atsaves et al.
LEUKEMIA (2017)
A blockade of PD-L1 produced antitumor and antimetastatic effects in an orthotopic mouse pancreatic cancer model via the PI3K/Akt/mTOR signaling pathway
Lei Zhao et al.
ONCOTARGETS AND THERAPY (2017)
Inhibitors of the PD-1/PD-L1 axis for the treatment of head and neck cancer: current status and future perspectives
Xiongwen Ran et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade
J. -P. Foy et al.
ANNALS OF ONCOLOGY (2017)
PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer
Riki Okita et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
PD-L1 Expression Confers Better Prognosis in Locally Advanced Oral Squamous Cell Carcinoma
Yasunao Kogashiwa et al.
ANTICANCER RESEARCH (2017)
Treatment outcome of PD-1 immune checkpoint inhibitor in Asian metastatic melanoma patients: correlative analysis with PD-L1 immunohistochemistry
Jinhyun Cho et al.
INVESTIGATIONAL NEW DRUGS (2016)
Actions of L-thyroxine and Nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells
Hung-Yun Lin et al.
STEROIDS (2016)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future
Lieping Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
Lars Henning Schmidt et al.
PLOS ONE (2015)
Immune Modulation in Cancer with Antibodies
David B. Page et al.
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myelogenous Leukemia
Marina Y. Konopleva et al.
CLINICAL CANCER RESEARCH (2014)
A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis
Kantima Leelahavanichkul et al.
MOLECULAR ONCOLOGY (2014)
PD-L1 Expression in Triple-Negative Breast Cancer
Elizabeth A. Mittendorf et al.
CANCER IMMUNOLOGY RESEARCH (2014)
The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
Xiaofeng Jiang et al.
CLINICAL CANCER RESEARCH (2013)
Oral cancer in Taiwan: is diabetes a risk factor?
Chin-Hsiao Tseng
CLINICAL ORAL INVESTIGATIONS (2013)
HMGA2 Elicits EMT by Activating the Wnt/β-catenin Pathway in Gastric Cancer
Lang Zha et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
WNT10B/-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer
Peter Wend et al.
EMBO MOLECULAR MEDICINE (2013)
Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone
Hung-Yun Lin et al.
FASEB JOURNAL (2013)
The Role of Thyroid Hormone Signaling in the Prevention of Digestive System Cancers
Adam R. Brown et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Cell Survival during Complete Nutrient Deprivation Depends on Lipid Droplet-fueled β-Oxidation of Fatty Acids
Ainara G. Cabodevilla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
PTEN Loss Increases PD-L1 Protein Expression and Affects the Correlation between PD-L1 Expression and Clinical Parameters in Colorectal Cancer
Minmin Song et al.
PLOS ONE (2013)
EGF and TGF-beta(1) Effects on Thyroid Function
Gabriella Mincione et al.
JOURNAL OF THYROID RESEARCH (2011)
Convergence between Wnt-β-catenin and EGFR signaling in cancer
Tianhui Hu et al.
MOLECULAR CANCER (2010)
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Bryan T. MacDonald et al.
DEVELOPMENTAL CELL (2009)
Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated
Hung-Yun Lin et al.
CARCINOGENESIS (2008)
Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells
Faith B. Davis et al.
CANCER RESEARCH (2006)
Wnt/Wingless signaling through β-catenin requires the function of both LRP/Arrow and frizzled classes of receptors -: art. no. 4
L Schweizer et al.
BMC CELL BIOLOGY (2003)
Integrin αvβ3 expression in colon carcinoma correlates with survival
A Vonlaufen et al.
MODERN PATHOLOGY (2001)
The structure of the β-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by β-catenin
AH Huber et al.
CELL (2001)
分享论文
